Objective: To evaluate the effectiveness of a pilot model engaging community pharmacists in the collaborative care of patients from a tertiary hospital, in terms of identification and resolution of drug-related problems (DRPs), and patients' acceptance and satisfaction with the program.
| INTRODUCTION
Pharmacy practice today continues to evolve into a more patient-centric mode of practice. Community pharmacists are the most accessible health professionals to the public and are therefore often the first point of contact in the health care system. 1 This has led to the development of community pharmacy practice to provide a wide range of health care services beyond medication dispensing, extending to medication review and disease management services, in several developed countries. [2] [3] [4] [5] [6] Pharmacists have been shown to play an important role in the management of polypharmacy and the reduction of drug-related problems (DRPs), thereby improving health outcomes in patients. 7, 8 In particular, several collaborations between community and hospital pharmacists, mainly in the Western countries, which provided medication review for older patients, have been shown to lead to a reduction in hospital readmissions 9, 10 and DRPs. 11, 12 In Singapore, local hospitals face a high patient load as well as space and resource constraints and therefore find it challenging to conduct thorough medication review and physical medication reconciliation for all patients. In light of this, optimizing the local current health care system to involve community pharmacists in the care of patients from public hospitals could potentially better cater to the health care needs of the older population. However, professional services by community pharmacists in Singapore are currently underutilized because of several reasons, one of which is the lack of government subsidies for medications should patients collect their medications from these community pharmacies. The current health care landscape in Singapore, as well as the community pharmacy practice scene in Singapore, were previously described in greater detail.
13
Project Octo-Pills therefore started as the first collaboration between a public hospital and community pharmacy in Singapore. 13 The name was inspired by the widespread network of community pharmacies in Singapore, branching out from the outpatient pharmacy of a tertiary hospital and academic medical center in Singapore, much like the arms or more medications, seeing three or more doctors, self-declared difficulty in managing their medications (eg, are confused and are unable to manage their own medications), or needing medication reconciliation (eg, suspected nonadherence to medication and have excessive medications at home). These criteria were selected based on factors which were commonly found to be associated with DRPs, such as polypharmacy and age-related physiological decline. [14] [15] [16] Once identified to be eligible, informed consent was obtained from each patient. Patients were excluded from the study if they were unable or unwilling to participate in this study or provide informed consent.
Upon obtaining consent, an appointment for a medication reconciliation and review session at a community pharmacy was made. Patients were able to pick a community pharmacy of their choice, based on their individual preferences for location and opening hours of the pharmacy. There were a total of 11 participating pharmacy stores spread within the country, which is approximately 720 km 2 in size, and well connected via an extensive rail network and a public transportation system. Next, a confirmation call was made 2 weeks after recruitment, and the patient was asked to bring all medications, including nutritional supplements, medications from private clinics, or traditional medications to the medication review session. They may also opt for the hospital's medication delivery service to send their medications from the hospital to the community pharmacy.
The hospital pharmacists compiled a case summary of each patient and sent it to the community pharmacists prior to the appointment. This included pertinent medical information such as the latest laboratory results, as well as the patient's medication list from the hospital and any other institutions in the public sector.
During the review session, the community pharmacist will perform medication reconciliation as well as a medication review. The review process was guided by the United Kingdom National Health Service's recommended patient-centered approach to managing polypharmacy. 17 Details from the medication review such as any DRPs and pharmacist recommendations were documented, and this information will be sent back to the hospital pharmacists for follow-up. The patient's medication list was updated where necessary. Patient information leaflets on medication storage condition and medication adherence were also given out to patients. These were available in English, as well as Chinese, which is the second most commonly used language in Singapore.
| Outcome measures
The primary outcome of this pilot study was the number and types of DRPs that were identified and resolved during or after the medication review. Secondary outcomes included assessing the potential feasibility and general acceptance of this initiative. The feasibility of the project was determined by a survey on patients' acceptance and satisfaction with the program, conducted upon completion of the study. The post review follow-up phone call involved collection of feedback and feasibility data and was conducted by an impartial investigator, who was not involved in the medication review. This follow-up was done 2 weeks after the review to allow time for resolution of DRPs that
were not able to be resolved during the review itself. The survey consisted of five questions that assessed whether they (a) had a better understanding of their medical conditions and related medications; (b) felt that the pharmacist was professional and knowledgeable and provided detailed counseling; (c) found the time and location convenient;
(d) were willing to continue participating in the project; and (e) felt that their overall experience with community pharmacy was improved. A five-point Likert-type scale (strongly agree to strongly disagree) was used to quantify responses. Qualitative responses were also obtained for each of these questions, where applicable.
In this study, a DRP is defined as per the American Society of Hospital Pharmacists' definition for a medicationrelated problem, which is "an event or circumstance involving medication therapy that actually or potentially interferes with an optimum outcome for a specific patient." 18 DRPs can be categorized into the following: untreated indication, improper drug selection, subtherapeutic dosage, failure to receive drug, overdosage, adverse drug reaction, drug interactions, and drug use without indication.
| Data collection
The pharmacist collected patients' background information before the visit to the community pharmacy. Baseline demographic data collected included age, sex, and ethnicity. Data was also collected for the number of medications, reasons for referral, and comorbidities. The Chronic Disease Score was calculated as an overall measure of comorbidity. 20 For the visit, the number and categories of DRPs detected and actions taken by community pharmacists were recorded. For the post review follow-up phone call, the scores for the responses to the survey were recorded.
| Data analysis
Summary statistics were used to report patient characteristics, the prevalence of DRPs, actions taken by community pharmacists, and the results of the feasibility survey. All analyses were performed using Microsoft Excel 2007 version software.
| RESULTS
A total of 75 patients were recruited from 26th October 2015 to 30th June 2016. During the phone call to confirm the date of appointment, 23 patients declined to attend the medication review session. The main reason cited for this was due to a busy schedule. Another 15 patients dropped out from the study as they requested to personally call back to arrange for the medication review session but failed to do so and were not contactable thereafter. A total of 37 patients completed the medication review sessions. During the post review follow-up phone call, an additional five patients were not contactable. In total, 32 patients completed the review and post review phone follow-up and were included in the analysis. Figure 1 shows a flow chart indicating patient numbers at different stages of the study.
Demographic characteristics of patients are summarized in Table 1 . The majority of patients were Chinese (n = 26, 81.3%), with the slight majority being female (n = 17, 53.1%). The mean (SD) age of the participants was 66.1 (10.0) years. The mean (SD) number of medications checked by the community pharmacists during the medication review was 11.8 (5.8). The main reasons for referral were the need for medication reconciliation (n = 27, 45.0%) and patients having more than six medications (n = 26, 43.3%). The top three comorbidities noted in the participants were high cholesterol, hypertension, and diabetes mellitus. The mean (SD) Chronic Disease Score of the patients was calculated to be 5.5 (2.9).
A total of 63 DRPs were identified during the medication review. Table 2 shows the number and categories of the DRPs identified. The top DRP identified was failure to receive drug (n = 21, 33.3%), which, in our study, were mainly due to nonadherence. Following the identification of DRPs, a total of 103 follow-up actions were performed (Table 3 ). The most common follow-up actions were the provision of patient education with regard to their conditions or medication regimen (n = 30, 29.1%) and reinforcement of adherence (n = 16, 15.5%). Via these actions, a total of 60 DRPs (95.2%) were deemed to be resolved. A total of 17 cases were referred back to the hospital pharmacists for continued follow-up for their DRPs.
Results of the feedback from post review follow-up phone call are shown in Figure 2 . Majority of the patients agreed or strongly agreed that they had a better understanding of their medical conditions and related medications after the medication review (n = 27, 84.4%). They also acknowledged that the community pharmacists were professional and knowledgeable and provided clear and detailed information about their medical conditions and medications (n = 25, 78.1%). Patients also felt that the medication review service was provided at a convenient time and location (n = 25, 78.1%). Eighteen (56.3%) of the participants agreed or strongly agreed in terms of willingness to continue to participate in the program. Overall, the service improved the patient's experience with community pharmacy (n = 27, 84.4%).
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Project Octo-Pills was the first collaboration between a public hospital and community pharmacy in Singapore. In this pilot study, older adult Singaporeans at greater risk of DRPs based on predetermined criteria were identified and referred to community pharmacists for follow-up. By doing so, this pilot practice model aims to provide patients with medication reconciliation and review services from more convenient locations close to their homes. This increased convenience may allow medication-taking behaviors to be assessed more accurately; hence, the DRPs identified in the present study may be a better reflection of its true prevalence among older adults.
In this study, a total of 63 DRPs were identified out of 379 medications reviewed. The most common DRP identified was "failure to receive drug" (n = 21, 33.3%). In our study, nonadherence was also defined as failure to receive 195 participants who completed the study, as high as 70.3% of them had issues with medication adherence. 21 In a study investigating the prevalence of DRPs in hospitalized patients prescribed polypharmacy (defined as the daily consumption of five or more medications) in an acute-care hospital in Singapore, of 347 patients with a mean age of 65.9 ± 17.7 years, noncompliance accounted for a significant 28.1% of all DRPs. 22 Further studies should be conducted to examine the reasons behind medication nonadherence in the local population so that targeted approaches may be adopted to improve adherence and hence patient outcomes. Following the identification of DRPs, a total of 103 follow-up actions were performed, most commonly the provision of patient education with regards to their conditions or medication regimen (n = 30, 29.1%) and reinforcement of adherence (n = 16, 15.5%), as shown in Table 3 . Via these actions, a total of 60 DRPs (95.2%) were deemed to be resolved. There have been a plethora of studies published internationally regarding the effectiveness of various pharmacist-led interventions on patient adherence in the community; however, due to significant heterogeneity, it is difficult to compare these studies. 23 Nevertheless, with a proper framework for community pharmacy adherence interventions, greater and consistent success in improving medication adherence is possible. Interventions would also need to be delivered repeatedly over time and adjusted when patients' circumstances change. 23 While this study showed a high rate of resolution of DRPs, it is not known whether these led to improved clinical outcomes nor if they persisted, as that was not the purpose of the study, and there was no long-term follow-up of these patients. Future prospective-controlled studies are required to evaluate the effectiveness of this practice model on important patient outcomes and its cost-effectiveness.
Also of note in this study was the high dropout rate, after patients agreed to participate. Of a total of 75 patients recruited initially, 23 patients declined for a medication review session to be arranged during the phone call to confirm the date of appointment, and another 15 patients dropped out even before the medication review session. Only 37 patients (49.3%) completed the medication review sessions, of which five were not contactable for the post review phone follow-up. This may suggest that the patients do not regard the review as important, which may in turn be due to a lack of public awareness regarding the role of community pharmacies in health care provision. There is a paucity collect their medications from the community pharmacies, meant that patients would prefer to collect medications from the hospital's outpatient pharmacy. As such, the patients felt that a further review with the community pharmacist did not add to their convenience, despite closer proximity to their homes. Furthermore, some participants also cited the limited choices of locations for the review. To encourage better participation of this initiative on a larger scale, extending medication subsidies to the local pharmacies may be considered by the relevant authorities. Future efforts should also expand the service to more community pharmacy stores.
This study has several limitations. Firstly, as the primary focus of this study was the identification of the prevalence and resolution rate of DRPs of patients involved in this new practice model, as well as patient feedback on the program, the study did not assess the impact of the model on patient outcomes. Therefore, data on improvement of clinical parameters is lacking. Nevertheless, the high rate of identification of DRPs and number of follow-up actions taken by the community pharmacists are encouraging and demonstrates that such a model is viable. Secondly, as the study involved a single hospital and a single community pharmacy chain, coupled with the relatively small sample size, the results may not be fully generalizable. Despite this limitation, it is important for this pilot study to have been undertaken, as the preliminary results and clinical and operational insights gained would be useful for stakeholders to perform further investigations to find out how the service can be improved and expanded in future. The implementation of this pilot model engaging community pharmacists in the collaborative care of patients from a tertiary hospital will help to ease the challenges of a rapidly growing aging population, increasing burden of chronic diseases, and rising health care costs.
| CONCLUSION
Project Octo-Pills is a pilot and potential future collaborative care model across the continuum from tertiary to primary care settings and vice versa, in which a community based medication review service is provided to identify and resolve DRPs in older patients. This study showed that in this model, community pharmacists can play an important role in identifying and resolving DRPs by providing patients with medication reconciliation and review services from a more convenient location within their neighborhood. Patients had positive experience and feedback about the role of community pharmacists in patient care. Study findings should be used by stakeholders to perform further investigations to find out how the service can be improved and expanded in future to meet the needs of the aging population of Singapore.
